COVID-19
COVID-19 hospitalization rates are highest among racial and ethnic minorities
What is COVID-19?
Coronavirus Disease 2019 (COVID-19) is a symptomatic disease diagnosed by testing positive for the virus along with having such symptoms as fever, chills, headache, sore throat, new smell or taste disorders, cough, shortness of breath, pneumonia or acute respiratory distress. A health professional must diagnose you with COVID-19.
Who is at risk for COVID-19?
- Everyone
- While everyone is at risk of getting COVID-19, some people may be more likely to get COVID-19 or experience severe illness
- Severe illness and death rates tend to be higher for racial and ethnic minorities
What type of research is being conducted?
- Currently, CTT is conducting COVID-19 Vaccine Studies
- COVID-19 Vaccine Studies do NOT involve live virus and patients will NOT be exposed to the virus as part of the study
Risk Factors for COVID-19
Not Social Distancing
Living in Hot Spot
Working or Living in Close Quarters
Ethnic/Racial Minorities
COVID-19 and Minorities
CTT & COVID-19 in the News
CTT COVID-19 Vaccine Study
Dr. Douglas Denham, chief medical director of CTT, talks to KENS5 about a new COVID-19 Vaccine Study being conducted by CTT.
CTT Selected for Vaccine Study
CTT Chief Medical Director, Dr. Douglas Denham, talks to Camilla Rambaldi about an upcoming COVID-19 Vaccine Study at CTT.
CTT to Begin Moderna Study
CTT Chief Medical Director, Dr. Douglas Denham, talks to KSAT reporter Deven Clarke about participating in the Moderna Phase 3 trial, as the only site in San Antonio .
CTT Seeking Minorities for COVID-19 Vaccine Trial
CTT Investigator, Dr. Ayoade Avworo, speaks to Jeremy Baker of KENS5 about the importance of minority participation in clinical trials.
CTT Selected for Phase 3 Vaccine Trial
CTT Chief Medical Director, Dr. Douglas Denham, talks to Jeremy Baker about CTT’s involvement in the Moderna upcoming COVID-19 Vaccine Study at CTT.
CTT Starting Moderna Trial
Dr. Douglas Denham, chief medical director of CTT, talks to Fox San Antonio about a new COVID-19 Vaccine Study being conducted by CTT.
CTT Seeks At-Risk Participants for COVID-19 Vaccine Trial
CTT Chief Medical Director, Dr. Douglas Denham, talks to Rivard Report about an upcoming COVID-19 Vaccine Study at CTT.
CTT Looking for Volunteers
CTT Recruitment Team Lead, Edna Arce, talks to Telemundo about the Moderna Phase 3 trial.
CTT Begins Pfizer COVID-19 Vaccine Trials
CTT President/CEO Kay Scroggins, RN talks to KSAT’s Deven Clarke about CTT conducting the Pfizer COVID-19 vaccine trial.
First Moderna Patient in S. Texas at CTT
San Antoinio Express News was on hand to document the historic contribution of Mary Dixson as the first patient to receive an injection in the area from Dr. Ayo Avworo at CTT.
Participate in COVID-19 Studies
Participate in a COVID-19 clinical trial in San Antonio, TX to help us find a solution to the COVID-19 pandemic through medical science. There’s no cost to you or insurance required. Compensation is available. It’s easy, just browse currently enrolling studies and apply online to see if you qualify.
Thank you for your interest in participating in research at Clinical Trials of Texas, Inc. in San Antonio, TX. If you have any questions, we would love to hear from you! Please call us or message us, or for more information on clinical trials:
WHAT ARE CLINICAL RESEARCH STUDIES?
REASONS TO PARTICIPATE
ARE CLINICAL TRIALS SAFE?